Effects of actin filaments of fibrin clot structure and lysis
US5691160A · kind A · utility
14Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 1992 |
| Grant date | Nov 25, 1997 |
| Priority date | — |
| Expiry date | Aug 14, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/106664
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to therapeutic methods wherein an actin-binding protein, preferably gelsolin or DBP, is administered to a patient with actin-containing clots in order to remove actin from the clots. The invention also relates to diagnostic methods in which actin is removed from an actin-containing clot in vitro and quantitated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.